Upfront Immunotherapy for NSCLC – OncLive
OncLive |
Upfront Immunotherapy for NSCLC
OncLive We're going to talk first about immuno-oncology and immunotherapy. As you're aware of, immunotherapy is now clearly a very exciting advance in the treatment of lung cancer. We've seen several approvals for agents targeting the immune checkpoint … |
